Skip to main content
. 2022 Dec 12;22:1295. doi: 10.1186/s12885-022-10391-z

Table 3.

Common adverse events

Adverse Events All Grades Grade ≥ 3
TC group
(n = 34)
T group
(n = 61)
P TC group
(n = 34)
T group
(n = 61)
P
Any TEAE (≥ 1) 24(70.6) 36(59.0) 0.262 11(32.4) 8(13.1) 0.025
Leukopenia 18(52.9) 2(3.3) P < 0.001 3(8.9) 0(0.0) 0.018
Neutropenia 16(47.1) 3(4.9) P < 0.001 5(14.7) 0(0.0) 0.002
Anemia 16(47.1) 12(19.7) 0.005 3(8.9) 2(3.3) P < 0.001
Thrombocytopenia 17(50.0) 5(8.2) P < 0.001 3(8.9) 0(0.0) 0.018
Liver dysfunction 11(32.3) 9(14.8) 0.044 2(5.8) 2(3.3) 0.545
Creatinine elevation 5(14.7) 4(6.6) 0.194 0(0.0) 0(0.0)
Diarrhea 9(26.5) 13(21.3) 0.568 1(2.9) 1(1.6) 0.672
Vomiting 7(20.6) 2(3.3) 0.006 0(0.0) 0(0.0)
Stomatitis 8(23.5) 11(18.0) 0.521 0(0.0) 0(0.0)
Rash 19(55.6) 23(37.7) 0.087 4(11.7) 5(8.2) 0.569
Nail changes 7(20.6) 20(32.8) 0.268 1(2.9) 0(0.0) 0.178
Constipation 10(29.4) 6(10.0) 0.007 0(0.0) 0(0.0)

TEAE treatment-emergent adverse event